Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;17(3):146-51.
doi: 10.6091/ibj.1100.2013.

Colony forming unit endothelial cells do not exhibit telomerase alternative splicing variants and activity

Affiliations

Colony forming unit endothelial cells do not exhibit telomerase alternative splicing variants and activity

Armin Attar et al. Iran Biomed J. 2013.

Abstract

Introduction: Endothelial progenitor colony forming unit-endothelial cells (CFU-EC) were first believed to be the progenitors of endothelial cells, named endothelial progenitor cells. Further studies revealed that they are monocytes regulating vasculogenesis. The main hindrance of these cells for therapeutic purposes is their low frequency and limited replicative potentials. This study was undertaken to determine telomerase activity and alternative splicing variants in CFU-EC as a potential cause of limited replicative capacity in these cells.

Methods: CFU-EC were isolated from peripheral blood using a standard cell culture assay. Colonies were detached mechanically and alternative splicing variant mRNA were evaluated using real-time PCR. Telomerase enzyme activity was assessed using telomerase repeat amplification protocol. The same procedures were done on the cancer cell line Calu6 as the positive control.

Results: The cultured peripheral blood mononuclear cells formed colonies with spindle-shaped monocytic cells sprouted from the clusters. These morphological characteristics fulfill the definition of CFU-EC. Telomere length amplification protocol assay revealed no telomerase activity and real-time PCR showed no expression of telomerase enzyme mRNA in CFU-EC. Both parameters were significantly higher in the cancer cell line Calu6 taken as the positive control.

Conclusion: The absence of telomerase activity in the CFU-EC is a result of pre-transcriptional regulation of gene expression rather than other mechanisms for controlling telomerase activity such as post-transcriptional modifications. This finding can explain the limited proliferative activity of CFU-EC cells. We propose that absence of telomerase activity in CFU-EC can be attributable to their more mature monocytic nature that needs further investigations.

Keywords: Telomerase; Endothelial cells; Hemangioblast; Alternative splicing.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Deletion sites of different variants of hTERT and position of gene specific primers and their sequences. α-deletion site is located on exon 6, while β-deletion site is located on exons7 and 8. Using specific primers, the expression of full-length hTERT and three alternatively spliced variants (α-, ß- and αß-) were analyzed. Sequence of primers used for real-time PCR evaluation of different variants of hTERT expression and β-actin as the house-keeping gene have been shown in the adjacent Table. Exo, exon
Fig. 2
Fig. 2
A colony of colony-forming unit endothelial cells.  The cultured peripheral blood mononuclear cells, typically formed colonies with spindle-shaped cells, sprouted from the clusters
Fig. 3
Fig. 3
Real-time RT-PCR amplication graph. Low to absent levels of human telomerase reverse transcriptase alternative splicing variant was noted during real-time PCR cycles, despite the high levels of  -actin defined as red and green lines
Fig. 4
Fig. 4
Real-time RT-PCR data. The analysis of RT-PCR data showed no expression of human telomerase reverse transcriptase alternative splicing variants in colony forming unit-endothelial cells. The α-actin mRNA, taken as the internal control, was significantly amplified

References

    1. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998 Jul;92(2):362–7. - PubMed
    1. Asahara T, Murohara T, Sullivan A, Silver M, Zee RVD, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997 Feb;275:964–7. - PubMed
    1. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003 Feb;348(7):593–600. - PubMed
    1. Lin C, Rajakumar A, Plymire DA, Verma V, Markovic N, Hubel CA. Maternal Endothelial Progenitor Colony-Forming Units With Macrophage Characteristics Are Reduced in Preeclampsia. Am J Hypertens. 2009 Sep;22(9):1014–9. - PMC - PubMed
    1. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1584–95. - PMC - PubMed

Publication types

LinkOut - more resources